Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Second Affiliated Hospital Of Guangxi Medical University

Clinical trials sponsored by Second Affiliated Hospital Of Guangxi Medical University, explained in plain language.

Trials to join now! 1

Stroke patients may get a second chance with early tirofiban

Disease control Recruiting now

This study looks at whether giving the drug tirofiban soon after the standard clot-busting drug tenecteplase can help people recover better from a stroke. About 348 adults who had a stroke and received tenecteplase will be enrolled. The goal is to see if this combination reduces …

Phase: PHASE3 • Sponsor: Second Affiliated Hospital of Guangxi Medical University • Aim: Disease control

Last updated Jun 27, 2026 08:07 UTC